(1S,12S,14R)-9-(2H3)methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol

• ChemBase编号: 169562
• 分子式: C17H21NO3
• 平均质量: 287.35354
• 单一同位素质量: 287.15214354
• SMILES: C1[C@H]2[C@@]3(C=C[C@@H]1O)c1c(CN(CC3)C)ccc(c1O2)OC
• Canonical SMILES: COc1ccc2c3c1O[C@@H]1[C@@]3(CCN(C2)C)C=C[C@@H](C1)O
• InChI: InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1
• InChIKey: ASUTZQLVASHGKV-JDFRZJQESA-N

名称和登记号

名称

• IUPAC标准名: (1S,12S,14R)-9-(^2H₃)methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^1,^1^2.0^6,^1^7]heptadeca-6(17),7,9,15-tetraen-14-ol
• IUPAC传统名: (1S,12S,14R)-9-(^2H₃)methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^1,^1^2.0^6,^1^7]heptadeca-6(17),7,9,15-tetraen-14-ol
• 别名: 4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-(methoxy-d3)-11-methyl-6H-benzofurol[3a,3,2,-ef][2]benzazepin-6-ol; BRN 0093736-d3; Galantamin-d3; Galantamina-d3; Galantamine-d3; (-)-Galanthamine-d3; Jilkon-d3; Lycoremin-d3; Lycoremine-d3; NSC 100058-d3; Galanthamine-O-methyl-d3

登记号

• CAS号: 1279031-09-2
• PubChem SID: 162263694
• PubChem CID: 45039329

理论计算性质

• Acid pKa: 14.810377
• 质子受体: 4
• 质子供体: 1
• LogD (pH = 5.5): -1.9891269
• LogD (pH = 7.4): -0.35530484
• Log P: 1.1630428
• 摩尔折射率: 82.3049 cm^3
• 极化性: 31.64852 Å^3
• 极化表面积: 41.93 Å^2
• 可自由旋转的化学键: 1
• 里宾斯基五规则: true

分子性质

理化性质

• 溶解度: CH2Cl2; MeOH; THF
• 外观: light yellow Solid
• 熔点: 115-118°C

安全信息

• 保存条件: -20°C Freezer

详细说明

Toronto Research Chemicals - G188502

A deuterated selective acetylcholinesterase inhibitor. Useful for the treatment of Alzheimer's disease.

参考文献

• Bickel, U., et al.: Clin. Pharmacol. Ther., 50, 420 (1991)
• Maelicke, A., et al.: Drugs Dis Today, 1, 53 (1991)
• Sauvaltre, T., et al.: J. Med. Chem., 50, 5311 (1991)